Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
05/16/2002 | US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases |
05/16/2002 | US20020058652 Pharmaceutical compositions and methods for use |
05/16/2002 | US20020058618 Method for the treatmennt or prevention of a disease mediated by the alpha-2B-adrenoceptor |
05/16/2002 | DE10056312A1 New 1-(N-substituted amidoalkyl) bicyclic uracil derivatives useful as medicaments for treating ischemia or reperfusion damage, are poly-(ADP-ribose)-synthetase inhibitors |
05/16/2002 | CA2428784A1 Oral pharmaceutical composition containing a block copolymer |
05/16/2002 | CA2427350A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands |
05/16/2002 | CA2421594A1 3-substituted oxindole beta 3 agonists |
05/16/2002 | CA2421154A1 Peroxisome proliferator activated receptor alpha agonists |
05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
05/15/2002 | EP0778833B1 Endothelin receptor antagonists |
05/15/2002 | EP0748314B1 Tetrasubstituted imidazole derivatives, method for preparing the same, use thereof as drugs, and pharmaceutical compositions containing the same |
05/15/2002 | CN1349542A Heterocyclic compounds, intermediates thereof and elastase inhibitors |
05/15/2002 | CN1349531A Cyanopyrroles as progesterone receptor agonists |
05/15/2002 | CN1349528A Pyrimidine compounds |
05/15/2002 | CN1349527A Substituted benzolactam compounds |
05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
05/15/2002 | CN1349514A Pesticidal triazine derivatives |
05/15/2002 | CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
05/15/2002 | CN1349506A Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
05/15/2002 | CN1349500A 3,3-substituted indoline derivatives |
05/15/2002 | CN1348956A Substituted diazacycloheptane compound, medicine composite contg. same and the use thereof |
05/15/2002 | CN1084751C Palladium catalyzed indolization |
05/15/2002 | CN1084750C Process for producing cefazolin |
05/15/2002 | CN1084619C Process for preparing medicine composition |
05/15/2002 | CN1084618C Use of serotonin antagonists (5HT3) for treatment disease |
05/14/2002 | US6388091 In presence of a halosilane compound; crystallization, purification |
05/14/2002 | US6388071 Alkynyl phenyl heteroaromatic glucokinase activators |
05/14/2002 | US6387992 Heat, oxidation and light resistance |
05/14/2002 | US6387941 Antiserotonine agents |
05/14/2002 | US6387940 Heterocyclylmethyl-substituted pyrazole derivatives |
05/14/2002 | US6387939 Plant safening agnets; fungicide |
05/14/2002 | US6387938 Benzimidazole derivatives |
05/14/2002 | US6387937 Indole derivatives |
05/14/2002 | US6387926 Inhibitors of farnesyl protein transferase |
05/14/2002 | US6387923 Antiproliferative agents; anticancer agents |
05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
05/14/2002 | US6387915 Isoxazole-sulfonamide endothelin antagonists |
05/14/2002 | US6387903 Inhibitors of prenyl-protein transferase |
05/14/2002 | US6387900 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents |
05/14/2002 | US6387898 Treatment for CNS injuries |
05/10/2002 | WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity |
05/10/2002 | WO2002036576A1 Phthalazinone derivatives |
05/10/2002 | WO2002036575A1 Tagging compounds and process for use in aida libraries |
05/10/2002 | WO2002036564A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors |
05/10/2002 | WO2002036562A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
05/10/2002 | WO2002036558A2 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
05/10/2002 | WO2002036162A2 Compositions for treatment of ocular neovascularization and neural injury |
05/10/2002 | WO2002036119A1 Δ2,-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke |
05/10/2002 | WO2002036116A2 Tripeptidyl peptidase inhibitors |
05/10/2002 | WO2002036073A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
05/10/2002 | WO2002020437A3 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them |
05/10/2002 | WO2002018349A3 Process and intermediates for preparing retroviral protease inhibitors |
05/10/2002 | WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
05/10/2002 | WO2001070706A3 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
05/10/2002 | WO2001038324A3 Imidazole derivatives and their use as raf kinase inhibitors |
05/10/2002 | WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
05/10/2002 | CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity |
05/10/2002 | CA2426026A1 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
05/09/2002 | US20020055519 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
05/09/2002 | US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
05/09/2002 | US20020055469 Anticoagulants |
05/09/2002 | US20020055437 Stability of liquid formulations of various pesticides can be enhanced by utilizing quaternary ammoniuim salts |
05/09/2002 | US20020055071 Antisoilants; reduce staining due to the residue of sensitizing dyess occuring during processing; antideposit agents; free of deposition of precipitates during low-temperature storage; storage stability; digital cameras |
05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
05/08/2002 | EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
05/08/2002 | EP1202989A1 Benzamide derivatives |
05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
05/08/2002 | EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
05/08/2002 | EP1202734A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
05/08/2002 | CN1348449A Heteroaryl diazacycloalkanes, their preparation and use |
05/08/2002 | CN1348363A Novel pharmaceutical salt form |
05/08/2002 | CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor |
05/08/2002 | CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
05/07/2002 | US6384232 Radiology, hypoxic tissue cytotoxins, radiosensitizers; react n-(2,3-epoxypropyl)phthalimide with 2-nitro-imidazole; 6-((2-nitro-1h-imidazol-1-yl)methyl)-5-oxa-4,8-diaza undecane-2,10-dione dioxime compounds |
05/07/2002 | US6384222 N-benzenesulfonyl-L-proline compounds, preparation method and method for using the compounds in therapy |
05/07/2002 | US6384042 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes |
05/07/2002 | US6384032 Inhibitors of IL-12 production |
05/07/2002 | CA2098612C Arthropodicidal carboxanilides |
05/02/2002 | WO2002034744A1 Quinazoline derivatives |
05/02/2002 | WO2002034743A1 Triazole derivatives and pharmaceutical compositions comprising them |
05/02/2002 | WO2002034742A1 Aziridinylquinolinedione derivatives and process for their preparation |
05/02/2002 | WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
05/02/2002 | WO2002034725A1 Substituted phenyluracils |
05/02/2002 | WO2002034718A1 Amide derivatives as nmda receptor antagonists |
05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
05/02/2002 | WO2002034263A1 Preventives/remedies for portal hypertension |
05/02/2002 | WO2002005822A3 Compositions containing therapeutically active components having enhanced solubility |
05/02/2002 | WO2001081305A3 Methylation of indole compounds using dimethy carbonate |
05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |